JameAbrahamMD

Oncology • Cleveland, OH

Breast Cancer, Hematologic Oncology

Chairman, Department of Hematology and Medical Oncology, Taussig Cancer Institute; Professor of Medicine, Cleveland Clinic

Join to view full profile

Dr. Abraham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abraham's full profile

Already have an account?

Office
9500 Euclid Avenue
Taussig Cancer institute, Cleveland Clinic
Cleveland, OH 44195
Phone+1 216-444-6833

Summary

Professor of Medicine at Lerner College of Medicine of Cleveland Clinic and Director of Breast Oncology Program at Taussig Cancer Institute, Cleveland Clinic. Member of Breast Cancer Working Committee and Breast Cancer Translational Commitee of NRG Oncology Research Group. Principal Investigator of NSABP studies at Cleveland Clinic. Co- PI of the NCI CTN - LAPS grant at case comprehensive cancer center.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1997 - 2001
University of ConnecticutResidency, Internal Medicine, 1994 - 1997
Calicut Medical CollegeClass of 1991

Certifications & Licensure

OH State Medical License 2013 - 2025
PA State Medical License 2024 - 2024
WV State Medical License 2000 - 2014
CT State Medical License 1996 - 2001
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Certificate for one of Highest Accruing Principal Investigators in the Country, CTEP National Cancer Institute, 2013
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Nominated as Outstanding Faculty of the Year Award Department of Medicine, West Virginia University, 2012
Selected to the Gold Human Honor Society (GHHS) West Virginia University, 2011
"Pink Tie Guy" Susan G. Komen for the Cure, 2010
Dean's Award for Excellence in Clinical Medicine School of Medicine, West Virginia University, 2010
Quality Award (Customer Satisfaction) West Virginia University Hospitals, 2010
President of India, Her Excellency, Smt. Pratibha Patil "Vaidya Bhooshan" Pazhassi Raja Trust, New Delhi, India, 2010
Deans award for excellence in patient care School of medicine, wvu, 2009
Best in the Class West Virginia University Hospitals, 2009
Bonnie Wells Wilson Eminent Scholar and Distinguished Professor in Breast Cancer Research 2009
First Bonnie Wells Wilson Distinguished Professor and Eminent Scholar in Breast Cancer Research West Virginia University, 2009
Outstanding Achievement in Medicine Kerala Center, India League, New York, 2008
Outstanding Faculty Award Department of Medicine, West Virginia University, 2007
Listed in Best Doctors in America® 2007
STAR Award for Customer Service West Virginia University Hospital, 2006
Clinician of the Year Award Department of Medicine, West Virginia University, 2006
Volunteer of the Year Award for the State of West Virginia American Cancer Society (ACS), 2006
Selected as one of the "Top Ten Employees" Mary Babb Randolph Cancer Center, 2005
Nominated for the Outstanding Faculty of the Year Award Department of Medicine, West Virginia University, 2005
Selected as one of the "100 Most Influential Persons" in Morgantown, WV Dominion Post Newspaper, 2005
Selected as one of the "Top Doctors of America" Consumer Research Council of America, Washington, DC, 2005
Fellow American College of Physicians (FACP), 2004
Idea Award Department of Defense, Breast Cancer Research Program, 2001
Career Development Award Department of Defense, Breast Cancer Research Program, 2001
Merit Award for the Fellows American Society of Clinical Oncology (ASCO), 2001
Nominated as the Clinician of the Year Department of Medicine, West Virginia University, 200, 2008
Nominated for the Clinician of the Year Award Department of Medicine, West Virginia University, 200, 200, 2004
U.S. News Top Doctor Castle Connolly Medical Ltd (Top 1% in the country), 20, 2012
Top 99th Percentile in Customer Satisfaction Press Ganey Survey, 20, 2012
Pfizer/Roerig Prize Washington Society for the History of Medicine, 1998
Howard Levine, M.D., Science Award Primary Care Internal Medicine Residency Program, University of Connecticut, 1996-1997
Research Studentship Indian Council of Medical Research (ICMR) for Medical Students, New Delhi, India, 1988
National Merit Scholarship Government of India, 1981
Join now to see all

Clinical Trials

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy Start of enrollment: 2000 Sep 01
Completed
Phase 1
Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer Start of enrollment: 2003 Jan 01
Completed
Phase 2
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer Start of enrollment: 2004 Jul 01
Unknown status
Phase 3
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer Start of enrollment: 2004 Sep 15
Completed
Phase 3
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer Start of enrollment: 2005 Apr 01
Completed
Phase 2
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon Start of enrollment: 2006 Mar 01
Terminated
Phase 2
Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum Start of enrollment: 2006 Jun 01
Withdrawn
Phase 2
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer Start of enrollment: 2006 Aug 01
Completed
Phase 2
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer Start of enrollment: 2001 Nov 01
Completed
Phase 2
Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers Start of enrollment: 2006 Nov 01
Completed
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer Start of enrollment: 2007 Feb 01
Completed
Phase 1, Phase 2
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer Start of enrollment: 2007 May 01
Completed
Phase 2
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer Start of enrollment: 2007 Jul 01
Unknown status
Phase 3
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab Start of enrollment: 2008 Apr 01
Terminated
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Start of enrollment: 2010 Jan 01
Completed
Phase 2
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Start of enrollment: 2009 May 01
Completed
Phase 3
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
Withdrawn
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 Start of enrollment: 2009 Apr 01
Unknown status
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer Start of enrollment: 2010 Oct 01
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation Start of enrollment: 2010 Jul 01
Completed
Phase 2
Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation Start of enrollment: 2010 Oct 12
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28 Start of enrollment: 2011 Oct 01
Unknown status
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer Start of enrollment: 2011 May 01
Completed
Phase 1
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial Start of enrollment: 2011 Nov 01
Unknown status
Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer Start of enrollment: 2017 May 19
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

140 citations
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity.
Ali Aminian, Rickesha Wilson, Abbas Al-Kurd, Chao Tu, Alex Milinovich
JAMA. 2022-06-28
6 citations
Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy.
Chirag Shah, Elizabeth Obi, Martin C. Tom, Bindu V. Manyam, Betty B. Obi
The Breast Journal. 2020-02-01
428 citations
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
William J Gradishar, Meena S Moran, Jame Abraham, Rebecca Aft, Doreen Agnese
Journal of the National Comprehensive Cancer Network. 2022-06-01

Journal Articles

Palliative Care Training during Fellowship: A National Survey of US Hematology and Oncology Fellows
Thomas RA, Curley B, Wen S, Zhang J, Abraham J, Moss AH,, J Palliat Med, 1/22/2015
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in wome...
Abraham J, Robidoux A, Tan AR, Limentani S, Sturtz K, Shalaby I, Alcorn H, Buyse ME, Wolmark N, Jacobs SA, Breast Cancer Res Treat, 1/1/2015
Radiation Exposure in Patients with Newly Diagnosed Breast Cancer within First Year from Diagnostic Procedures
Chaudhary L., Knapp S., Hester S., Wen S., Xiao J., Marano G., Kurian S., Hazard H., Layne G., Jacobson G., Abraham J., Journal of Community and Supportive Oncology, 1/1/2015
Exploring the Biology of Chemo-brain: Role of PET Scan: Imaging
Haut M., Marano G., Abraham J., Medicine, 1/1/2013
Predicted vs Measured VO2peak in Overweight and Obese Hormone-negative Breast Cancer Survivors
Swisher A., Bonner D., Gilleland D., Abraham J., Garcia J., Hobbs G., Kurian S., Reynolds A., Watts B., Yanosik M., Vona-Davis L., Med & Sci Sport Exerc, 1/1/2013
Weight (wt) Change in Patients with Treatment of Breast Cancer
Chaudhary L., Wen S., Xiao J., Swisher A, Kurian S, Abraham J., Journal of Community Supportive Oncology, 1/12/2012
Perceived Risk of Breast Cancer Recurrence
Kelly, Ajmera, Bhattacharjee, Hobbs, Chaudhary, Abraham J., Agnese D., Patient Education and Counseling, 1/9/2012
Extended Follow-up of an Antibiotic Cycling Program for the Management of Febrile Neutropenia in a Hematologic Malignancy and Hematopoietic Cell Transplantation Unit
Cumpston A., Craig M., Hamadani M., Abraham J., Hobbs GR., Sarwari AR., Transplant Infectious Disease, 1/1/2012
Nasal Septum Perforation Induced by Bevacizumab Therapy in Patients with Breast Cancer: Case Report and Literature Review
Chaudhary L., Wilkinson R., Jordan C., Price A., Filburn S., Abraham J., Community Oncology, 1/1/2012
Medical Education in India: Time to Make Some Changes
Jayakrishnan T., Honhar M., Jolly G., Abraham J., National Medical Journal of India, 1/1/2012
mTOR as a Target in Breast Cancer: Emerging Role of Everolimus
Newton M., Nagaiah G., Abraham J., Breast Cancer Management, 1/1/2012
Breast Cancer as a Global Disease: Editorial
Veltri L., Abraham J., Breast Cancer Management, 1/1/2012
Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Following Fludarabine, Busulfan-Based Red...
Hamadani M., Craig M., Phillips G., Abraham J., Tse W., Cumpston A., Gibson L., Remick S., Bunner P., Leadmon S., Elder P., Hofmeister C., Penza S., Efebera Y., Andrit..., Hematol Oncol, 1/28/2011
A Phase I Study of Infusional Paclitaxel with the P-Glycoprotein Antagonist, PSC 833
Chico I., Bergen R., Abraham J., et al, Journal of Clinical Oncology, 1/15/2011
Novel HER-2 Targeted Therapy for Breast Cancer
Abraham J., Community Oncology, 1/1/2011
Cognitive Dysfunction in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
Batalo M., Nagaiah G., Abraham J., Expert Rev Anticancer Ther, 1/1/2011
Achieving Career Success in Academic Oncology
Almubarak M., Abraham J., Oncology Fellows, 1/1/2010
Role of Circulating Tumor Cells in the Management of Breast Cancer
Nagaiah G., Abraham J., Clinical Breast Cancer, 1/1/2010
Endocrine Therapy for Metastatic Breast Cancer
Virani S., Abraham J., Emerging Cancer Therapeutics, 1/1/2010
Triple-Negative Breast Cancer in WV
Abraham J., Hazard H., Jubilier S., et al, West Virginia Medical Journal, 1/1/2009
Serum Levels of HER-2/neu, a Potential Alternative to Tissue Specimen in the Management of Breast Cancer: A Case Report and Literature Review
Swayampakula A., Gadiyarm V., Abraham J., Community Oncology, 1/1/2009
A Study of US-Based Indian and Pakistani Population with Cancer Diagnosis Reported in the SEER Database from 1988 to 2003
Hossain A., Abraham J., Cancer, 1/15/2008
Trastuzumab and Cardiac Toxicity: Monitoring in Adjuvant Setting
Saad A., Abraham J., Community Oncology, 1/1/2007
Individualized Survival and Treatment Response Predictions for Breast Cancers Using Phospho-EGFR, Phospho-ER, Phospho-HER-2/neu, Phsopho-IGF-IR/In, Phospho-MAPK, and P...
Guo L., Abraham J., Flynn D.C., Castranova V., Shi X., Qian Y., International Journal of Biological Markers, 1/1/2007
Pregnancy after Breast Cancer
Al Khouri N., Patrizio, P., Abraham, J., Commun Oncol, 1/1/2007
Join now to see all

Books/Book Chapters

Bethesda Handbook of Clinical Oncology
Chapter: Breast Cancer
Brendan Curley, Hannah Hazard, Geraldine Jacobson and Jame AbrahamLippincott Williams and Wilkins, PhiladelphiaEdition 4th,2014
Bethesda Handbook of Oncology
Abraham, Gulley and AllegraLippincott Williams and WilkinsEdition 3,
Bethesda Handbook of Clinical Hematology
Chapter: Hodgkin's Disease
Kanate, A., Craig, M., Abraham, J., Wilson, W.H., and Jaffe, E.Lippincott Williams and Wilkins, PhiladelphiaEdition 3rd,2012
Advances in the Management of Triple-Negative Breast Cancer
Chapter: Pathology and Diagnosis of Triple-Negative Breast Cancer
Nagaiah G., Abraham J.Editors: Dr. Clifford A Hudis and Dr. Tiffany A Traina.2011
Emerging Cancer Therapeutics
Chapter: Endocrine Therapy for Metastatic Breast Cancer
Shamsuddin Virani and Jame AbrahamEditors: Antoinette Tan.2010
The Essentials of Clinical Oncology
Chapter: Plasma Cell Neoplasm-Multiple Myeloma
Pamela Jeyaraj, MD, Abraham Kanate, MD, and Jame Abraham, MDEditors: Robert D. Marsh, J. Samuel.Edition 3rd,2010
ASCO Educational Book
Chapter: Cardiovascular Safety and Toxicity Profile of New Molecularly Targeted Anticancer Agents
Saad A., Beto R., Abraham J., Remick S.2008
The Essentials of Clinical Oncology
Chapter: Principles of Chemotherapy
Ramin Altaha, MD, Mohammed Almubarak, MD, and Jame Abraham, MDEditors: Robert D. Marsh, J. Samuel.Edition 2nd,2008
The Essentials of Clinical Oncology
Chapter: Targeted Novel Treatments in Oncology
Mohammed Almubarak, MD, Ramin Altaha, MD, and Jame Abraham, MDEditors: Robert D. Marsh, J. Samuel.Edition 2nd,2008
The Essentials of Clinical Oncology
Chapter: Hematopoietic Stem Cell Transplantation
Mohammed Almubarak, MD, Ramin Altaha, MD, and Jame Abraham, MDEditors: Robert D. Marsh, J. Samuel.Edition 2nd,2008
Breast Cancer an Essential Guide
Chapter: Trastuzumab for Breast Cancer
Mirshahidi, H. and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
Breast Cancer an Essential Guide
Chapter: Supportive Care for Patients with Breast Cancer
Sharma, M. and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
Breast Cancer an Essential Guide
Chapter: Novel Targeted Therapies
Higa, G. and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
Breast Cancer an Essential Guide
Chapter: Chemotherapy for Breast Cancer
Sehbai, A., Asif, N., and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
Breast Cancer an Essential Guide
Chapter: Genetics and Genetic Counseling
Mirza, M. and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
Breast Cancer an Essential Guide
Chapter: Biology of Breast Cancer
Kanate, A. and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
Breast Cancer an Essential Guide
Chapter: Anatomy of the Breast
Kanate, A. and Abraham, J.Lippincott Williams and Wilkins, Philadelphia2007
A Companion to Essentials of Clinical Oncology
Chapter: Cancer Related Pathology
Sehbai, A., Abraham, J., Thomas, A., et alEditors: Pavithran and Samuel.Mehta Publications, New Delhi, India2006
A Companion to Essentials of Clinical Oncology
Chapter: Breast Cancer
Sehbai, A. and Abraham, J.Editors: Pavithran and Samuel.Mehta Publications, New Delhi, India2006
A Companion to Essentials of Clinical Oncology
Chapter: Targeted Therapies
Sehbai, A. and Abraham, J.Editors: Pavithran and Samuel.Mehta Publications, New Delhi, India2006
A Companion to Essentials of Clinical Oncology
Chapter: Genito Urinary Cancers
Sehbai, A. and Abraham, J.Editors: Pavithran and Samuel.Mehta Publications, New Delhi, India2006
Bethesda Handbook of Clinical Oncology
Chapter: Acute Leukemia
Craig, M., Abraham, J., and Monhan, B.Lippincott Williams and Wilkins, PhiladelphiaEdition 2nd,2005
Bethesda Handbook of Clinical Oncology
Chapter: Hodgkin's Disease
Schunn, G., Abraham, J., and Devetten, M.Lippincott Williams and Wilkins, PhiladelphiaEdition 2nd,2005
Bethesda Handbook of Clinical Oncology
Chapter: Hematopoietic Stem Cell Transplantation
Craig, M., Abraham, J., and Childs, R.Lippincott Williams and Wilkins, PhiladelphiaEdition 2nd,2005
The Essentials of Clinical Oncology
Chapter: Bone Marrow Transplantation
Abraham, J. and Altaha, R.Editors: Robert D. Marsh and J. Samuel.2005
Join now to see all

Abstracts/Posters

Graded Prognostic Assessment (GPA) for Her2 positive Breast Cancer with Brain Metastases (BCBM) in a Contemporary Cohort.
Chi M, Venur VA, Mohammadi AM et al, American Society of Clinical Oncology (ASCO), 1/1/2015
New graded prognostic assessment (GPA) in breast cancer brain metastases in a contemporary cohort.
Ahluwalia M, Chi M, Venur VA, Budd T, et al, San Antonio Breast Cancer Symposium (SABCS), 1/1/2014
Graded prognostic assessment for triple negative breast cancer brain metastases.
Chi M, Venur VA, Abraham J, Budd T et al, San Antonio Breast Cancer Symposium (SABCS), 1/1/2014
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel (WP) or eribulin (E) followed by doxorubicin and cyclophosphamid...
Jame Abraham, MD, Andre Robidoux, MD, Antoinette R. Tan, MD, Marc E. Buyse, PhD, ScD Norman Wolmark, MD, Samuel A. Jacobs, MD, ASCO, 1/1/2014
New graded prognostic index for breast cancer patients (pts) with brain metastases (BCBM).
Manmeet Singh Ahluwalia, Lingling Du, Vyshak Alva Venur, Lilyana Angelov, Samuel T. Chao, Paul Elson, Alireza Mohammad Mohammadi, David M. Peereboom, G. Thomas Budd, G..., ASCO, 1/1/2014
Newton. Assessing the impact of a targeted electronic medical record intervention on growth factor usage in cancer patients.
J. Bernens, K. Hartman, B. Curley, S. Wen, J. Abraham, M. Newton, ASCO Quality Symposium, 1/1/2014
Detection of axillary lymph node metastases and extra-axillary metastases with FDG PET/CT in breast cancer patients undergoing neoadjuvant chemotherapy.
Geraldine Jacobson, Gary Marano, Jame Abraham, Cancer Imaging and Radiation Therapy Symposium, Orlando, FL, 1/8/2013
Weight (wt) change in patients (pts) with treatment of breast cancer (BC).
Lubna Chaudhary, Sijin Wen, Jie Xiao, Anne Swisher, Sobha Kurian and Jame Abraham, ASCO Breast Cancer Symposium, San Francisco, CA, 1/1/2013
Radiation exposure in patients (pts) with newly diagnosed breast cancer (BC) within first year (yr) from diagnostic procedures (DP).
Lubna Chaudhary, Sarah Knapp, Samuel Hester, Sijin Wen, Jie Xiao, Gary Marano, Sobha Kurian, Hannah Hazard, Ginger Layne, Geraldine Jacobson, Jame Abraham, ASCO Breast Cancer Symposium, San Francisco, CA, 1/1/2013
Epidemiologic and survival characteristics of breast cancer (BC) among the US Asian Indian and Pakistani women compared with other US population groups: A SEER databas...
Shahzad Raza, Akm Mosharraf Hossain, Rubayat Rahman, Carl Freter, Jame Abraham, ASCO Breast Cancer Symposium, San Francisco, CA, 1/1/2013
Get Fit for the Fight ®: Effects of an Exercise and Nutritional Intervention on Quality of Life in Overweight Survivors of Triple Negative Breast Cancer.
Sarah Lewis SPT, Abby Newman SPT; Daniel Bonner MS; Diana Gilleland MBA; Mary Anne Yanosik RD; Sobha Kurian MD; Jame Abraham MD; Linda Vona-Davis PhD; Anne Swisher, PT..., The West Virginia Physical Therapy Association's Spring Conference, Stonewall Resort, Roanoke, WV, 1/1/2013
Predicted vs. measured VO2peak in overweight and obese hormone-negative breast cancer survivors.
Anne K. Swisher PT, PhD, CCS; Daniel Bonner BS, ATC; Diana Gilleland BS, MBA; Jame Abraham MD; Jessica Garcia DPT; Gerald Hobbs PhD; Sobha Kurian MD; Alexandra Reynold..., ACSM Meeting, 1/1/2013
An Economic Rationale to Develop a Statewide West Virginia Cancer Clinical Trials Network (WVCTN): Impact of Out-migration of Cancer Care.
Gurley-Calvez T, Keresztury J, Monga M, Bose S, Naim J, Filburn S, Madhavan S, Petros W, Shah A, Frame JN, Abraham J, Witt T, and Remick SC, Multiple Events, Multiple locations, 1/1/2013
Incidence and Pattern of Graft-Versus host Disease in Patients Undergoing Allogeneic Hematopoitic Stem Cell Transplantation after Non-Myeloablative Conditioning with T...
Lauren Veltri, Michael Regier, Abraham Kanate, Aaron Cumpston, Sonia Leadmon, Jame Abraham, Michael Craig, Mehdi Hamadani, ASBMT, 1/1/2013
Pilot Study Utilizing Fluorine-18 fluorodeoxyglucose (F-18 FDG) Positron Emission Tomography-Computed Tomography Scan (PET-CT Scan) to Investigate Brain Metabolic Chan...
Sean Troung, Shamsudding Virani, Rachel Lagos, Gerald Hobbs, Gary Marano, Jame Abraham, International Cognitive Function Task Force Conference, Paris, France, 1/1/2012
Frequency and Severity of Wrist and Hand Problems in Breast Cancer Survivors Taking Aromatase Inhibitors.
Swisher, Anne, Abraham, Jame, Kurian, Sobha, Survivorship Research Conference, Arlington, VA, 1/1/2012
A phase I dose-escalation study evaluating weekly paclitaxel with neratinib and trastuzumab in women with metastatic HER2-positive breast cancer, NSABP FB-8.
Rachel Catherine Jankowitz, Jame Abraham, Antoinette R. Tan, Steven A. Limentani, Laura M Adamson, Marc E. Buyse, Samuel A. Jacobs, Norman Wolmark; National Surgical A..., ASCO, 1/1/2012
Pilot Study Utilizing Fluorine-18 fluorodeoxyglucose (F-18 FDG) Positron Emission Tomography-Computed Tomography Scan (PET-CT Scan) to Investigate Brain Metabolic Chan...
Rachel Lagos, Gerald Hobbs, Gary Marano, Jame Abraham, RSNA, 1/1/2012
Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (AHCT) Following Fludarabine/Busulfan/ATG...
Mehdi Hamadani, Michael Craig, Jame Abraham, William Tse, Aaron Cumpston, Laura Gibson, Scot Remick, Sonia Leadmon, Patrick Elder, Craig Hofmeister, Sam Penza, Leslie ..., Hematol Oncol, 1/28/2011
Pilot Study Utilizing Fluorine-18 fluorodeoxyglucose (F-18 FDG) Positron Emission Tomography-Computed Tomography Scan (PET-CT Scan) to Investigate Brain Metabolic Chan...
Shamsuddin Virani, Rachel Lagos, Gerald Hobbs, Gary Marano, Jame Abraham, San Antonio Breast Cancer Symposium, 1/1/2011
Functional Pathways Analysis of Primary Human AML Samples Using Single Cell Network Profiling (SCNP) Provides New Insights Into Individual Patient Biology.
Todd M Covey, Michael Gulrajani, Rachael Hawtin, Urte Gayko, Aaron Cumpston, Michael Craig, Sayed Hamadani, Angela Rishel, Jino Park, Jame Abraham, Scot Remick, and Wi..., ASBMT, HI, 1/1/2011
In Vivor T-Cell Depletion (TCD) Does Not Improve Rates of Graft-Versus-Host Disease (GVHD) and Transplantation Outcomes in Patients Undergoing Peripheral Blood Allogen...
Abraham S Kanate, MD, Salman Osman, MD, Aaron Cumpston, Pharm D, Gerry Hobbs, PhD, Sonia Leadmon, BS, Pamela Bunner, MT, Laura Gibson, PhD, William Tse, MD, Jame Abrah..., American Society of Hematology, Orlando, FL, 1/1/2010
Cyclophosphamide (CY)/G-CSF Cannot Completely Overcome ImiD-Induced Impairment of Peripheral Blood Stem Cell (PBSC) Mobilization (Mob) in Patients with Multiple Myelom...
Salman Osman, Abraham Kanate, Pamela Bunner, Sonia Leadmon, Kelli Hart, Londia Goff, William Tse, Aaron Cumpston, Scot Remick, Jame Abraham, Michael Craig, and Mehdi H..., American Society of Hematology, Orlando, FL, 1/1/2010
Decline in the Use of Erythropoiesis-Stimulating Agents: Long Term Effects of Regulation, Reimbursement, and Unfavorable Data.
Muhammad A. Mirza, Michael Newton, Renee Sager, and Jame Abraham, ASCO Annual Meeting, Chicago, IL, 1/1/2010
Colon Cancer Disparities: A SEER-Based Analysis of Epidemiologic Data on Asian and Pakistani Immigrants in the United States.
A. Hossain, MD, MPH, R. Rahman, MD, MPH, and J. Abraham, MD, FACP, AASCO Annual Meeting, Chicago, IL, 1/1/2010
Join now to see all

Lectures

NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib (N) in women with metastatic HER2+ breast cancer (MBC).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Management of Metastatic Breast Cancer.
1/10/2015
Breast Cancer update 2014.
1/5/2015
Breast Cancer Treatment an update.
1/1/2015
Her-2 targeted treatment.
1/5/2014
Genomic Medicine in Breast Cancer: Hype or Hope.
Grand Rapids, MI - 1/1/2014
Personalized Medicine, Hype or Hope.
1/1/2014
Why doctors do not want to talk to you.
1/1/2014
Breast Cancer treatment of the future.
1/1/2014
Breast cancer: What a primary care doctor needs to know.
Las Vegas, NV - 1/1/2014
Metastatic Breast Cancer.
1/1/2014
Breast Cancer San Antonio Update.
1/1/2014
WVOS Spring Membership Conference - Clinical and Legislative Issues Impacting Cancer Care in West Virginia
West Virginia Oncology Society (WVOS), Daniels, West Virginia - 4/19/2013
Changing Clinical Trial Landscape in the U.S.
1/1/2013
Her-2 targeted therapy for breast cancer.
Las Vegas, NV - 1/1/2013
Cancer as a major cause of mortality in India: Changing Trends of Cancer Incidence in India.
Kochi, India - 1/1/2013
Increasing cancer incidence in India.
Delhi, India - 1/1/2012
Breast Cancer Present and Future.
1/1/2012
Best of Community Translations.
Las Vegas, NV - 1/1/2012
Novel Her-2 targeted therapies.
Las Vegas, NV - 1/28/2011
Doctor Patient Communication in the iPhone Age.
1/9/2011
"Breast Cancer Update 2011"
1/7/2011
Life as an Academic oncologist.
1/1/2011
Drug Discovery in Oncology.
1/1/2011
Breast Cancer: Is it in my genes?
Charleston, WV - 1/30/2010
Join now to see all

Other

"Bethesda Handbook of Clinical Oncology, Fourth Edition, (ISBN: 0-787-2300-0) Lippincott-Williams and Wilkins, Philadelphia"
Jame Abraham MD, Carmen Allegra MD, and James Gulley MD, PhD, National Cancer Institute, National Institutes of Health (Editors)
www.lww.com
1/1/2014
Lessons from Pink.
Abraham J., Community Oncology
1/1/2013
Ipilimumab: New Treatment for melanoma.
Abraham J., Community Oncology
1/1/2010
ALK inhibitors: New treatment for lung cancer.
Abraham J., Community Oncology
1/1/2010
Provenge for Prostate cancer.
Abraham J., Community Oncology
1/1/2010
Novel TKIs for chronic myeloid Leukemia.
Abraham J., Community Oncology
1/1/2010
Sentinel Lymph Node evaluation for breast cancer.
Abraham J., Community Oncology
1/1/2010
Cabazitaxel for Prostate cancer.
Abraham J., Community Oncology
1/1/2010
Eribulin: Novel Taxane for breast cancer.
Abraham J., Community Oncology
1/1/2010
Treatment of CLL.
Abraham J., Community Oncology
1/1/2010
Oncotype DX for colon cancer.
Abraham J., Community Oncology
1/1/2010
Her-2 targeted treatment for gastric cancer.
Abraham J., Community Oncology
1/1/2010
Avastin for breast cancer.
Abraham J., Community Oncology
1/1/2010
Non anthracycline containing regimens for breast cancer.
Abraham J.
1/1/2010
"Smoking habits in cancer survivors"
Abraham J., Expert of the Day, FOX National Radio Network
1/19/2009
PARP inhibitors in breast cancer.
Abraham J., Community Oncology
1/1/2009
Role of Bisphosphanates in early stage breast cancer.
Abraham J., Community Oncology
1/1/2009
"Bethesda Handbook of Clinical Oncology, Third Edition, (ISBN: 0-787-2300-0) Lippincott-Williams and Wilkins, Philadelphia"
Jame Abraham MD, Carmen Allegra MD, and James Gulley MD, PhD, National Cancer Institute, National Institutes of Health (Editors)
1/1/2009
K-ras testing.
Abraham J., Community Oncology
1/1/2008
Totect (dexrazoxane) for treatment of anthracycline extravasation.
Abraham J., Community Oncology
1/1/2008
Caphosol: New Treatment for Mucositis.
Abraham J., Community Oncology
1/1/2008
Eculizumab for paroxysmal nocturnal hemoglobinuria.
Abraham J., Community Oncology
1/1/2008
Bendamustine: New Treatment options for CLL.
Abraham J., Community Oncology
1/1/2008
Genetic profiling for cancer of unknown primary.
Abraham J., Community Oncology
1/1/2008
NPlate Novel treatment for ITP.
Abraham J., Community Oncology
1/1/2008
Join now to see all

Authored Content

Dr Jame Abraham of Cleveland Clinic on When Doctors Feel VulnerableNovember 2021
All the News That's Fit to Tweet: ESMO 2020September 2020
3 Studies Presented at SABCS That Will Change Our PracticeDecember 2019
3 Studies Presented at SABCS That Will Change Our PracticeDecember 2019
'What Special Area of Knowledge Do You Bring to the Oncology World?'June 2019
'What Special Area of Knowledge Do You Bring to the Oncology World?'June 2019
Join now to see all

Press Mentions

India to Suffer from ‘Tsunami’ of Chronic Diseases: Oncologist Advises This to Reshape Cancer CareJanuary 19th, 2023
India to Face ‘Tsunami’ of Chronic Diseases like Cancer Due to Globalization, Growing Economy, Aging Population and Changing Lifestyle: US-Based OncologistJanuary 18th, 2023
Stomatitis Risk with Everolimus Reduced by Slow Dose EscalationJanuary 5th, 2023
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Association for Cancer Research - AACR
Member
American College of Physicians - ACP
Member

Other Languages

Hindi, Urdu